NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0334788795733948 |
0.28740936 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0334788795733948 |
0.11744622 |
NSC 149765 |
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) |
0.0334788795733948 |
-0.093877596 |
NSC 178248 |
Chlorozotocin |
0.0334788795733948 |
0.12045318 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.0334788795733948 |
0.4371758 |
NSC 625624 |
7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- |
0.0334788795733948 |
0.34732106 |
NSC 628684 |
Null |
0.0334788795733948 |
0.4570397 |
NSC 122060 |
Ethanesulfonic acid, compd. with N-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]metanilyl fluoride (1:1) (8CI) (MF2) |
0.0393863597626316 |
0.29309084 |
NSC 122131 |
Null |
0.0393863597626316 |
0.21797257 |
NSC 145669 |
4(1H)-Quinazolinone, 2,3-dihydro-2-(1-naphthalenyl)- (9CI) |
0.0393863597626316 |
0.20457009 |